These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 28589759

  • 1. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study.
    Shrestha R, Giri S, Armitage JO, Bhatt VR.
    Future Oncol; 2017 Jun; 13(14):1239-1246. PubMed ID: 28589759
    [Abstract] [Full Text] [Related]

  • 2. Changing incidence of myeloproliferative neoplasms: trends and subgroup risk profiles in the USA, 1973-2011.
    Deadmond MA, Smith-Gagen JA.
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2131-8. PubMed ID: 25968903
    [Abstract] [Full Text] [Related]

  • 3. Analysis of clinical characteristics of bone marrow proliferative tumor progression to acute myeloid leukemia.
    Li Y, Zhang XY, Han J, Wang L.
    Cancer Biomark; 2018 Dec; 23(4):469-472. PubMed ID: 30452397
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24,577 first-degree relatives of 11,039 patients with myeloproliferative neoplasms in Sweden.
    Landgren O, Goldin LR, Kristinsson SY, Helgadottir EA, Samuelsson J, Björkholm M.
    Blood; 2008 Sep 15; 112(6):2199-204. PubMed ID: 18451307
    [Abstract] [Full Text] [Related]

  • 7. Increased risk of lymphoid neoplasms in patients with Philadelphia chromosome-negative myeloproliferative neoplasms.
    Vannucchi AM, Masala G, Antonioli E, Chiara Susini M, Guglielmelli P, Pieri L, Maggi L, Caini S, Palli D, Bogani C, Ponziani V, Pancrazzi A, Annunziato F, Bosi A.
    Cancer Epidemiol Biomarkers Prev; 2009 Jul 15; 18(7):2068-73. PubMed ID: 19531676
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Myeloproliferative disorders].
    Binder D, Fehr J.
    Ther Umsch; 2004 Feb 15; 61(2):131-42. PubMed ID: 15018396
    [Abstract] [Full Text] [Related]

  • 10. [Utility of bone marrow biopsy in the diagnosis of myeloproliferative neoplasm].
    Tovar-Bobadilla JL, Ortiz-Hidalgo C.
    Gac Med Mex; 2016 Feb 15; 152(3):407-18. PubMed ID: 27335198
    [Abstract] [Full Text] [Related]

  • 11. Risk of thrombosis, hemorrhage and leukemic transformation in patients with myeloproliferative neoplasms: A nationwide longitudinal cohort study.
    Hur JY, Choi N, Choi JH, Kim J, Won YW.
    Thromb Res; 2024 Apr 15; 236():209-219. PubMed ID: 38461615
    [Abstract] [Full Text] [Related]

  • 12. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.
    Cerquozzi S, Tefferi A.
    Blood Cancer J; 2015 Nov 13; 5(11):e366. PubMed ID: 26565403
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Working classification of chronic myeloproliferative disorders based on histological, haematological, and clinical findings.
    Burkhardt R, Bartl R, Jäger K, Frisch B, Kettner G, Mahl G, Sund M.
    J Clin Pathol; 1986 Mar 13; 39(3):237-52. PubMed ID: 3457024
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?
    Björkholm M, Hultcrantz M, Derolf ÅR.
    Best Pract Res Clin Haematol; 2014 Jun 13; 27(2):141-53. PubMed ID: 25189725
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.